DECLARE TIMI 58 (Completed)
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)
- Medicine
- dapagliflozin
- Population
- Diabetes mellitus
- Phase
- III
- Starting year
- 2013
- More information
- ClinicalTrials.gov